10,151 reports of this reaction
1.5% of all ABATACEPT reports
#13 most reported adverse reaction
SYNOVITIS is the #13 most commonly reported adverse reaction for ABATACEPT, manufactured by E.R. Squibb & Sons, L.L.C.. There are 10,151 FDA adverse event reports linking ABATACEPT to SYNOVITIS. This represents approximately 1.5% of all 665,237 adverse event reports for this drug.
Patients taking ABATACEPT who experience synovitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SYNOVITIS is a less commonly reported adverse event for ABATACEPT, but still significant enough to appear in the safety profile.
In addition to synovitis, the following adverse reactions have been reported for ABATACEPT:
The following drugs have also been linked to synovitis in FDA adverse event reports:
SYNOVITIS has been reported as an adverse event in 10,151 FDA reports for ABATACEPT. This does not prove causation, but indicates an association observed in post-market surveillance data.
SYNOVITIS accounts for approximately 1.5% of all adverse event reports for ABATACEPT, making it a notable side effect.
If you experience synovitis while taking ABATACEPT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.